The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women of reproductive age. Obesity is frequently present in these patients and plays a key role in the pathogenesis of both the endocrine and metabolic abnormalities of the syndrome, particularly infertility, hyperandrogenism an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chatzis Panagiotis, Tziomalos Konstantinos, Pratilas Georgios C., Makris Vasileios, Sotiriadis Alexandros, Dinas Konstantinos
Format:	Artigo
Idioma:	Inglês
Publicat:	Pensoft Publishers 2018-12-01
Col·lecció:	Folia Medica
Matèries:	orlistat liraglutide naltrexone polycystic ovary syndrome obesity
Accés en línia:	http://www.degruyter.com/view/j/folmed.2018.60.issue-4/folmed-2018-0036/folmed-2018-0036.xml?format=INT
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!